BIOTECH FIRMS SEE NEW-DRUG UPSWING

摘要

BIO 2OO5 ROLLED INTO PHIL-adelphia last week with an estimated 18,000 attendees and 1,500 exhibitors.The Biotechnology Industry Organization,the event's sponsor,claims both figures are records.If participation in BIO continues to grow,so does pressure on the biotechnology industry to deliver on its promise of new therapies for diseases such as cancer,HIV,and central nervous system disorders.The need to expedite biotech drug discovery and development-a topic encompassing regulation,technology,and financing-dominated discussion in Philadelphia.